Studies have found that the predictive value of PD-L1 expression at different biopsy sites for the benefit of ICIs in NSCLC may vary, in which higher PD-L1 expression in distant metastases is significantly associated with better RR, PFS and OS [103]. Here, CD274 is linked to non-small cell lung carcinoma.